Tag: FDA bioequivalence

• DARREN LLOYD
• 2

Narrow therapeutic index drugs require stricter bioequivalence standards to ensure patient safety. Learn how the FDA, EMA, and Health Canada regulate generics like warfarin, levothyroxine, and digoxin to prevent dangerous dosing errors.